{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T22:28:42Z","timestamp":1794695322861,"version":"4.9.1"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:00:00Z","timestamp":1756339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:00:00Z","timestamp":1756339200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["21fk0410046"],"award-info":[{"award-number":["21fk0410046"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["23wm0325064"],"award-info":[{"award-number":["23wm0325064"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["20fk0108451s0101"],"award-info":[{"award-number":["20fk0108451s0101"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22H02877"],"award-info":[{"award-number":["22H02877"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22KK0277"],"award-info":[{"award-number":["22KK0277"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22K07089"],"award-info":[{"award-number":["22K07089"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["19H03703"],"award-info":[{"award-number":["19H03703"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22H03119"],"award-info":[{"award-number":["22H03119"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Takeda Science Foundation Intramural grant from Kumamoto University COVID-19 Research Projects"},{"name":"Takeda Science Foundation IMAI MEMORIAL TRUST FOR AIDS RESEARCH Shin-Nihon Foundation of Advanced Medical Research"},{"DOI":"10.13039\/100008206","name":"Australian Nuclear Science and Technology Organisation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008206","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["#1159272"],"award-info":[{"award-number":["#1159272"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["#034677"],"award-info":[{"award-number":["#034677"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>The emergence of SARS-CoV-2 Variants of Concern (VOC) is a major clinical threat; however, VOC remain susceptible to cytotoxic T lymphocyte (CTL) recognition. Therefore, it is crucial to identify potent CTL responses targeting conserved epitopes across VOCs. Here, we demonstrate that the nucleocapsid (N) protein induces efficient CTL responses in early pandemic COVID-19 convalescent donors. In the context of the <jats:italic>HLA-A24-B52-C12<\/jats:italic> haplotype, prevalent in Japan, the KF9 peptide (N<jats:sub>266-274<\/jats:sub>: KAYNVTQAF) is immunodominant and restricted by HLA-C*12:02. KF9-specific T cells are cytotoxic and suppress viral replication of both the ancestral and multiple VOC SARS-CoV-2. KF9-specific CD8<jats:sup>+<\/jats:sup> T cells maintain effector memory and terminally differentiated phenotypes for 12 months post-infection and proliferate rapidly upon recall. We also determine the structure of a TCR in the context of the HLA-C*12:02-KF9 complex, providing a prototype for the interaction of HLA-C with viral peptides. Surprisingly, despite the TCR\u2019s high affinity, the CDR3\u03b2 loop almost lacks contact with the KF9 peptide. These findings highlight the importance of conserved epitopes and the role of HLA-C molecules in controlling SARS-CoV-2 VOC.<\/jats:p>","DOI":"10.1038\/s41467-025-63288-3","type":"journal-article","created":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T17:18:05Z","timestamp":1756401485000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Molecular basis of potent antiviral HLA-C-restricted CD8+ T cell response to an immunodominant SARS-CoV-2 nucleocapsid epitope"],"prefix":"10.1038","volume":"16","author":[{"given":"Yoshihiko","family":"Goto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9008-9867","authenticated-orcid":false,"given":"You Min","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mako","family":"Toyoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Hamana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiki","family":"Aritsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Nakama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Tajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janesha C.","family":"Maddumage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mizuki","family":"Kitamatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8740-5371","authenticated-orcid":false,"given":"Hiroyuki","family":"Kishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Yonekawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhilshan","family":"Jayasinghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Shimono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoji","family":"Nagasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rumi","family":"Minami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Toya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0765-4221","authenticated-orcid":false,"given":"Noritaka","family":"Sekiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Tomita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Demetra S. M.","family":"Chatzileontiadou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotomo","family":"Nakata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1760-3839","authenticated-orcid":false,"given":"So","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuro","family":"Sakagami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4852-4236","authenticated-orcid":false,"given":"Takamasa","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7416-038X","authenticated-orcid":false,"given":"Stephanie","family":"Gras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9027-742X","authenticated-orcid":false,"given":"Chihiro","family":"Motozono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,28]]},"reference":[{"key":"63288_CR1","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.cell.2020.09.038","volume":"183","author":"C Rydyznski Moderbacher","year":"2020","unstructured":"Rydyznski Moderbacher, C. et al. Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity. Cell 183, 996\u20131012 e1019 (2020).","journal-title":"Cell"},{"key":"63288_CR2","doi-asserted-by":"publisher","first-page":"108728","DOI":"10.1016\/j.celrep.2021.108728","volume":"34","author":"AT Tan","year":"2021","unstructured":"Tan, A. T. et al. Early induction of functional SARS-CoV-2-specific T cells associates with rapid viral clearance and mild disease in COVID-19 patients. Cell Rep. 34, 108728 (2021).","journal-title":"Cell Rep."},{"key":"63288_CR3","doi-asserted-by":"crossref","unstructured":"Tarke, A. et al. Early and Polyantigenic CD4 T cell responses correlate with mild disease in acute COVID-19 donors. Int. J. Mol. Sci. 23, 7155 (2022).","DOI":"10.3390\/ijms23137155"},{"key":"63288_CR4","doi-asserted-by":"publisher","first-page":"100557","DOI":"10.1016\/j.xcrm.2022.100557","volume":"3","author":"A Chandran","year":"2022","unstructured":"Chandran, A. et al. Rapid synchronous type 1 IFN and virus-specific T cell responses characterize first wave non-severe SARS-CoV-2 infections. Cell Rep. Med 3, 100557 (2022).","journal-title":"Cell Rep. Med"},{"key":"63288_CR5","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1038\/s41591-023-02480-8","volume":"29","author":"A Papadopoulou","year":"2023","unstructured":"Papadopoulou, A. et al. SARS-CoV-2-specific T cell therapy for severe COVID-19: a randomized phase 1\/2 trial. Nat. Med. 29, 2019\u20132029 (2023).","journal-title":"Nat. Med."},{"key":"63288_CR6","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s41586-023-06331-x","volume":"620","author":"DG Augusto","year":"2023","unstructured":"Augusto, D. G. et al. A common allele of HLA is associated with asymptomatic SARS-CoV-2 infection. Nature 620, 128\u2013136 (2023).","journal-title":"Nature"},{"key":"63288_CR7","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1016\/j.immuni.2022.08.008","volume":"55","author":"A Bertoletti","year":"2022","unstructured":"Bertoletti, A., Le Bert, N. & Tan, A. T. SARS-CoV-2-specific T cells in the changing landscape of the COVID-19 pandemic. Immunity 55, 1764\u20131778 (2022).","journal-title":"Immunity"},{"key":"63288_CR8","doi-asserted-by":"publisher","first-page":"102178","DOI":"10.1016\/j.coi.2022.102178","volume":"76","author":"DG Augusto","year":"2022","unstructured":"Augusto, D. G. & Hollenbach, J. A. HLA variation and antigen presentation in COVID-19 and SARS-CoV-2 infection. Curr. Opin. Immunol. 76, 102178 (2022).","journal-title":"Curr. Opin. Immunol."},{"key":"63288_CR9","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s00251-022-01284-3","volume":"75","author":"A Srivastava","year":"2023","unstructured":"Srivastava, A. & Hollenbach, J. A. The immunogenetics of COVID-19. Immunogenetics 75, 309\u2013320 (2023).","journal-title":"Immunogenetics"},{"key":"63288_CR10","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1084\/jem.181.6.2085","volume":"181","author":"JA McCutcheon","year":"1995","unstructured":"McCutcheon, J. A., Gumperz, J., Smith, K. D., Lutz, C. T. & Parham, P. Low HLA-C expression at cell surfaces correlates with increased turnover of heavy chain mRNA. J. Exp. Med. 181, 2085\u20132095 (1995).","journal-title":"J. Exp. Med."},{"key":"63288_CR11","doi-asserted-by":"publisher","first-page":"171","DOI":"10.4049\/jimmunol.160.1.171","volume":"160","author":"A Neisig","year":"1998","unstructured":"Neisig, A., Melief, C. J. & Neefjes, J. Reduced cell surface expression of HLA-C molecules correlates with restricted peptide binding and stable TAP interaction. J. Immunol. 160, 171\u2013179 (1998).","journal-title":"J. Immunol."},{"key":"63288_CR12","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/eji.201040841","volume":"41","author":"K Honda","year":"2011","unstructured":"Honda, K. et al. Selection of escape mutant by HLA-C-restricted HIV-1 Pol-specific cytotoxic T lymphocytes carrying strong ability to suppress HIV-1 replication. Eur. J. Immunol. 41, 97\u2013106 (2011).","journal-title":"Eur. J. Immunol."},{"key":"63288_CR13","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1038\/s41590-020-0782-6","volume":"21","author":"Y Peng","year":"2020","unstructured":"Peng, Y. et al. Broad and strong memory CD4(+) and CD8(\u2009+\u2009) T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19. Nat. Immunol. 21, 1336\u20131345 (2020).","journal-title":"Nat. Immunol."},{"key":"63288_CR14","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.cell.2020.08.017","volume":"183","author":"T Sekine","year":"2020","unstructured":"Sekine, T. et al. Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19. Cell 183, 158\u2013168 e114 (2020).","journal-title":"Cell"},{"key":"63288_CR15","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/s41590-021-01084-z","volume":"23","author":"Y Peng","year":"2022","unstructured":"Peng, Y. et al. An immunodominant NP105-113-B*07:02 cytotoxic T cell response controls viral replication and is associated with less severe COVID-19 disease. Nat. Immunol. 23, 50\u201361 (2022).","journal-title":"Nat. Immunol."},{"key":"63288_CR16","doi-asserted-by":"publisher","first-page":"3962","DOI":"10.1016\/j.cell.2021.05.046","volume":"184","author":"S Weingarten-Gabbay","year":"2021","unstructured":"Weingarten-Gabbay, S. et al. Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs. Cell 184, 3962\u20133980 e3917 (2021).","journal-title":"Cell"},{"key":"63288_CR17","doi-asserted-by":"publisher","first-page":"e1010870","DOI":"10.1371\/journal.ppat.1010870","volume":"19","author":"CY Wang","year":"2023","unstructured":"Wang, C. Y. et al. Toward a pan-SARS-CoV-2 vaccine targeting conserved epitopes on spike and non-spike proteins for potent, broad and durable immune responses. PLoS Pathog. 19, e1010870 (2023).","journal-title":"PLoS Pathog."},{"key":"63288_CR18","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.1016\/j.cell.2023.04.007","volume":"186","author":"CM Arieta","year":"2023","unstructured":"Arieta, C. M. et al. The T-cell-directed vaccine BNT162b4 encoding conserved non-spike antigens protects animals from severe SARS-CoV-2 infection. Cell 186, 2392\u20132409 e2321 (2023).","journal-title":"Cell"},{"key":"63288_CR19","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/j.chom.2021.06.006","volume":"29","author":"C Motozono","year":"2021","unstructured":"Motozono, C. et al. SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity. Cell Host Microbe 29, 1124\u20131136 (2021).","journal-title":"Cell Host Microbe"},{"key":"63288_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33068-4","volume":"13","author":"C Motozono","year":"2022","unstructured":"Motozono, C. et al. The SARS-CoV-2 Omicron BA.1 spike G446S mutation potentiates antiviral T-cell recognition. Nat. Commun. 13, 5440 (2022).","journal-title":"Nat. Commun."},{"key":"63288_CR21","doi-asserted-by":"crossref","unstructured":"Jureka, A. S., Silvas, J. A. & Basler, C. F. Propagation, inactivation, and safety testing of SARS-CoV-2. Viruses 12, 622 (2020).","DOI":"10.3390\/v12060622"},{"key":"63288_CR22","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1111\/tan.12536","volume":"85","author":"N Ikeda","year":"2015","unstructured":"Ikeda, N. et al. Determination of HLA-A, -C, -B, -DRB1 allele and haplotype frequency in Japanese population based on family study. Tissue Antigens 85, 252\u2013259 (2015).","journal-title":"Tissue Antigens"},{"key":"63288_CR23","doi-asserted-by":"publisher","first-page":"e0214323","DOI":"10.1128\/spectrum.02143-23","volume":"11","author":"TTT Dang","year":"2023","unstructured":"Dang, T. T. T. et al. Breadth and Durability of SARS-CoV-2-Specific T Cell responses following long-term recovery from COVID-19. Microbiol Spectr. 11, e0214323 (2023).","journal-title":"Microbiol Spectr."},{"key":"63288_CR24","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/s10038-020-0771-5","volume":"65","author":"K Kiyotani","year":"2020","unstructured":"Kiyotani, K., Toyoshima, Y., Nemoto, K. & Nakamura, Y. Bioinformatic prediction of potential T cell epitopes for SARS-Cov-2. J. Hum. Genet 65, 569\u2013575 (2020).","journal-title":"J. Hum. Genet"},{"key":"63288_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15924","volume":"8","author":"G Kaur","year":"2017","unstructured":"Kaur, G. et al. Structural and regulatory diversity shape HLA-C protein expression levels. Nat. Commun. 8, 15924 (2017).","journal-title":"Nat. Commun."},{"key":"63288_CR26","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/j.immuni.2021.04.009","volume":"54","author":"THO Nguyen","year":"2021","unstructured":"Nguyen, T. H. O. et al. CD8(+) T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope display high naive precursor frequency and TCR promiscuity. Immunity 54, 1066\u20131082 e1065 (2021).","journal-title":"Immunity"},{"key":"63288_CR27","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1042\/BST20210410","volume":"49","author":"AT Nguyen","year":"2021","unstructured":"Nguyen, A. T., Szeto, C. & Gras, S. The pockets guide to HLA class I molecules. Biochem Soc. Trans. 49, 2319\u20132331 (2021).","journal-title":"Biochem Soc. Trans."},{"key":"63288_CR28","doi-asserted-by":"publisher","first-page":"4790","DOI":"10.4049\/jimmunol.1401689","volume":"193","author":"M Rasmussen","year":"2014","unstructured":"Rasmussen, M. et al. Uncovering the peptide-binding specificities of HLA-C: a general strategy to determine the specificity of any MHC class I molecule. J. Immunol. 193, 4790\u20134802 (2014).","journal-title":"J. Immunol."},{"key":"63288_CR29","doi-asserted-by":"crossref","unstructured":"Szeto, C., Lobos, C. A., Nguyen, A. T. & Gras, S. TCR Recognition of Peptide-MHC-I: Rule Makers and Breakers. Int. J. Mol. Sci. 22, 68 (2020).","DOI":"10.3390\/ijms22010068"},{"key":"63288_CR30","doi-asserted-by":"publisher","first-page":"5323","DOI":"10.1093\/bioinformatics\/btz517","volume":"35","author":"R Gowthaman","year":"2019","unstructured":"Gowthaman, R. & Pierce, B. G. TCR3d: The T cell receptor structural repertoire database. Bioinformatics 35, 5323\u20135325 (2019).","journal-title":"Bioinformatics"},{"key":"63288_CR31","doi-asserted-by":"crossref","unstructured":"Zareie, P. et al. Canonical T cell receptor docking on peptide-MHC is essential for T cell signaling. Science 372, eabe9124 (2021).","DOI":"10.1126\/science.abe9124"},{"key":"63288_CR32","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.immuni.2016.09.007","volume":"45","author":"S Gras","year":"2016","unstructured":"Gras, S. et al. Reversed T cell receptor docking on a major histocompatibility Class I complex limits involvement in the immune response. Immunity 45, 749\u2013760 (2016).","journal-title":"Immunity"},{"key":"63288_CR33","doi-asserted-by":"publisher","first-page":"12826","DOI":"10.1073\/pnas.1921964117","volume":"117","author":"MJW Sim","year":"2020","unstructured":"Sim, M. J. W. et al. High-affinity oligoclonal TCRs define effective adoptive T cell therapy targeting mutant KRAS-G12D. Proc. Natl. Acad. Sci. USA 117, 12826\u201312835 (2020).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"63288_CR34","doi-asserted-by":"crossref","unstructured":"Sim, M. J. W. et al. T cells discriminate between groups C1 and C2 HLA-C. Elife 11, e75670 (2022).","DOI":"10.7554\/eLife.75670"},{"key":"63288_CR35","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.str.2023.11.011","volume":"32","author":"V Mikhaylov","year":"2024","unstructured":"Mikhaylov, V. et al. Accurate modeling of peptide-MHC structures with AlphaFold. Structure 32, 228\u2013241 e224 (2024).","journal-title":"Structure"},{"key":"63288_CR36","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1038\/s42003-021-02885-6","volume":"4","author":"K Shimizu","year":"2021","unstructured":"Shimizu, K. et al. Identification of TCR repertoires in functionally competent cytotoxic T cells cross-reactive to SARS-CoV-2. Commun. Biol. 4, 1365 (2021).","journal-title":"Commun. Biol."},{"key":"63288_CR37","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.immuni.2023.02.017","volume":"56","author":"M Koutsakos","year":"2023","unstructured":"Koutsakos, M. et al. SARS-CoV-2 breakthrough infection induces rapid memory and de novo T cell responses. Immunity 56, 879\u2013892 e874 (2023).","journal-title":"Immunity"},{"key":"63288_CR38","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1126\/science.1143767","volume":"317","author":"J Fellay","year":"2007","unstructured":"Fellay, J. et al. A whole-genome association study of major determinants for host control of HIV-1. Science 317, 944\u2013947 (2007).","journal-title":"Science"},{"key":"63288_CR39","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/QAD.0b013e32831db247","volume":"23","author":"D van Manen","year":"2009","unstructured":"van Manen, D., Kootstra, N. A., Boeser-Nunnink, B. & Handulle, M. A. van't Wout A. B., Schuitemaker H. Association of HLA-C and HCP5 gene regions with the clinical course of HIV-1 infection. AIDS 23, 19\u201328 (2009).","journal-title":"AIDS"},{"key":"63288_CR40","doi-asserted-by":"publisher","first-page":"100520","DOI":"10.1016\/j.xcrm.2022.100520","volume":"3","author":"H Ishii","year":"2022","unstructured":"Ishii, H. et al. Neutralizing-antibody-independent SARS-CoV-2 control correlated with intranasal-vaccine-induced CD8(+) T cell responses. Cell Rep. Med 3, 100520 (2022).","journal-title":"Cell Rep. Med"},{"key":"63288_CR41","doi-asserted-by":"publisher","first-page":"15812","DOI":"10.1073\/pnas.2634931100","volume":"100","author":"P Zhu","year":"2003","unstructured":"Zhu, P. et al. Electron tomography analysis of envelope glycoprotein trimers on HIV and simian immunodeficiency virus virions. Proc. Natl. Acad. Sci. USA 100, 15812\u201315817 (2003).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"63288_CR42","doi-asserted-by":"publisher","first-page":"40867","DOI":"10.1074\/jbc.R112.399444","volume":"287","author":"SK Lee","year":"2012","unstructured":"Lee, S. K., Potempa, M. & Swanstrom, R. The choreography of HIV-1 proteolytic processing and virion assembly. J. Biol. Chem. 287, 40867\u201340874 (2012).","journal-title":"J. Biol. Chem."},{"key":"63288_CR43","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1038\/ni.2342","volume":"13","author":"H Chen","year":"2012","unstructured":"Chen, H. et al. TCR clonotypes modulate the protective effect of HLA class I molecules in HIV-1 infection. Nat. Immunol. 13, 691\u2013700 (2012).","journal-title":"Nat. Immunol."},{"key":"63288_CR44","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/nm0297-212","volume":"3","author":"PJ Goulder","year":"1997","unstructured":"Goulder, P. J. et al. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nat. Med 3, 212\u2013217 (1997).","journal-title":"Nat. Med"},{"key":"63288_CR45","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/35085576","volume":"412","author":"PJ Goulder","year":"2001","unstructured":"Goulder, P. J. et al. Evolution and transmission of stable CTL escape mutations in HIV infection. Nature 412, 334\u2013338 (2001).","journal-title":"Nature"},{"key":"63288_CR46","doi-asserted-by":"publisher","first-page":"110218","DOI":"10.1016\/j.celrep.2021.110218","volume":"38","author":"I Kimura","year":"2022","unstructured":"Kimura, I. et al. The SARS-CoV-2 Lambda variant exhibits enhanced infectivity and immune resistance. Cell Rep. 38, 110218 (2022).","journal-title":"Cell Rep."},{"key":"63288_CR47","doi-asserted-by":"publisher","first-page":"2936","DOI":"10.1016\/j.cell.2022.07.002","volume":"185","author":"G Dolton","year":"2022","unstructured":"Dolton, G. et al. Emergence of immune escape at dominant SARS-CoV-2 killer T cell epitope. Cell 185, 2936\u20132951 e2919 (2022).","journal-title":"Cell"},{"key":"63288_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34180-1","volume":"13","author":"S Swaminathan","year":"2022","unstructured":"Swaminathan, S. et al. Ablation of CD8(+) T cell recognition of an immunodominant epitope in SARS-CoV-2 Omicron variants BA.1, BA.2 and BA.3. Nat. Commun. 13, 6387 (2022).","journal-title":"Nat. Commun."},{"key":"63288_CR49","doi-asserted-by":"publisher","first-page":"e105938","DOI":"10.15252\/embj.2020105938","volume":"39","author":"Y Peng","year":"2020","unstructured":"Peng, Y. et al. Structures of the SARS-CoV-2 nucleocapsid and their perspectives for drug design. EMBO J. 39, e105938 (2020).","journal-title":"EMBO J."},{"key":"63288_CR50","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12985-023-01968-6","volume":"20","author":"W Wu","year":"2023","unstructured":"Wu, W., Cheng, Y., Zhou, H., Sun, C. & Zhang, S. The SARS-CoV-2 nucleocapsid protein: its role in the viral life cycle, structure and functions, and use as a potential target in the development of vaccines and diagnostics. Virol. J. 20, 6 (2023).","journal-title":"Virol. J."},{"key":"63288_CR51","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/mt.2015.210","volume":"24","author":"S Abdul-Jawad","year":"2016","unstructured":"Abdul-Jawad, S. et al. Increased valency of conserved-mosaic vaccines enhances the breadth and depth of epitope recognition. Mol. Ther. 24, 375\u2013384 (2016).","journal-title":"Mol. Ther."},{"key":"63288_CR52","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/j.immuni.2021.04.006","volume":"54","author":"KE Lineburg","year":"2021","unstructured":"Lineburg, K. E. et al. CD8(\u2009+\u2009) T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope cross-react with selective seasonal coronaviruses. Immunity 54, 1055\u20131065 e1055 (2021).","journal-title":"Immunity"},{"key":"63288_CR53","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/s41586-021-04280-x","volume":"602","author":"S Adamo","year":"2022","unstructured":"Adamo, S. et al. Signature of long-lived memory CD8(+) T cells in acute SARS-CoV-2 infection. Nature 602, 148\u2013155 (2022).","journal-title":"Nature"},{"key":"63288_CR54","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/s41590-022-01184-4","volume":"23","author":"AA Minervina","year":"2022","unstructured":"Minervina, A. A. et al. SARS-CoV-2 antigen exposure history shapes phenotypes and specificity of memory CD8(\u2009+\u2009) T cells. Nat. Immunol. 23, 781\u2013790 (2022).","journal-title":"Nat. Immunol."},{"key":"63288_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24377-1","volume":"12","author":"JH Jung","year":"2021","unstructured":"Jung, J. H. et al. SARS-CoV-2-specific T cell memory is sustained in COVID-19 convalescent patients for 10 months with successful development of stem cell-like memory T cells. Nat. Commun. 12, 4043 (2021).","journal-title":"Nat. Commun."},{"key":"63288_CR56","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/BF00216838","volume":"37","author":"S Karaki","year":"1993","unstructured":"Karaki, S. et al. HLA-B51 transgenic mice as recipients for production of polymorphic HLA-A, B-specific antibodies. Immunogenetics 37, 139\u2013142 (1993).","journal-title":"Immunogenetics"},{"key":"63288_CR57","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.1073\/pnas.87.7.2583","volume":"87","author":"J Yamamoto","year":"1990","unstructured":"Yamamoto, J., Kariyone, A., Akiyama, N., Kano, K. & Takiguchi, M. Presentation of human minor histocompatibility antigens by HLA-B35 and HLA-B38 molecules. Proc. Natl. Acad. Sci. USA 87, 2583\u20132587 (1990).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"63288_CR58","doi-asserted-by":"crossref","unstructured":"Shu, Y. & McCauley, J. GISAID: Global initiative on sharing all influenza data - from vision to reality. Euro Surveill. 22, 30494 (2017).","DOI":"10.2807\/1560-7917.ES.2017.22.13.30494"},{"key":"63288_CR59","doi-asserted-by":"publisher","first-page":"e42613","DOI":"10.1016\/j.heliyon.2025.e42613","volume":"11","author":"J Wu","year":"2025","unstructured":"Wu, J., Kryukov, K., Takeuchi, J. S. & Nakagawa, S. SGV-caller: SARS-CoV-2 genome variation caller. Heliyon 11, e42613 (2025).","journal-title":"Heliyon"},{"key":"63288_CR60","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.bbrc.2016.05.015","volume":"474","author":"H Hamana","year":"2016","unstructured":"Hamana, H., Shitaoka, K., Kishi, H., Ozawa, T. & Muraguchi, A. A novel, rapid and efficient method of cloning functional antigen-specific T-cell receptors from single human and mouse T-cells. Biochem Biophys. Res. Commun. 474, 709\u2013714 (2016).","journal-title":"Biochem Biophys. Res. Commun."},{"key":"63288_CR61","doi-asserted-by":"publisher","first-page":"e1002805","DOI":"10.1371\/journal.ppat.1002805","volume":"8","author":"L Fadda","year":"2012","unstructured":"Fadda, L. et al. HLA-Cw*0102-restricted HIV-1 p24 epitope variants can modulate the binding of the inhibitory KIR2DL2 receptor and primary NK cell function. PLoS Pathog. 8, e1002805 (2012).","journal-title":"PLoS Pathog."},{"key":"63288_CR62","doi-asserted-by":"publisher","first-page":"100635","DOI":"10.1016\/j.xpro.2021.100635","volume":"2","author":"DSM Chatzileontiadou","year":"2021","unstructured":"Chatzileontiadou, D. S. M., Szeto, C., Jayasinghe, D. & Gras, S. Protein purification and crystallization of HLA-A *02:01 in complex with SARS-CoV-2. Pept. STAR Protoc. 2, 100635 (2021).","journal-title":"Pept. STAR Protoc."},{"key":"63288_CR63","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1107\/S1600577518003120","volume":"25","author":"D Aragao","year":"2018","unstructured":"Aragao, D. et al. MX2: a high-flux undulator microfocus beamline serving both the chemical and macromolecular crystallography communities at the Australian Synchrotron. J. Synchrotron Radiat. 25, 885\u2013891 (2018).","journal-title":"J. Synchrotron Radiat."},{"key":"63288_CR64","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1107\/S0907444909047337","volume":"66","author":"W Kabsch","year":"2010","unstructured":"Kabsch, W. Xds. Acta Crystallogr. D. Biol. Crystallogr. 66, 125\u2013132 (2010).","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"63288_CR65","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1107\/S0907444994003112","volume":"50","author":"Collaborative Computational Project N","year":"1994","unstructured":"Collaborative Computational Project N The CCP4 suite: programs for protein crystallography. Acta Crystallogr. D. Biol. Crystallogr 50, 760\u2013763 (1994).","journal-title":"Acta Crystallogr. D. Biol. Crystallogr"},{"key":"63288_CR66","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1107\/S0021889807021206","volume":"40","author":"AJ McCoy","year":"2007","unstructured":"McCoy, A. J. et al. Phaser crystallographic software. J. Appl. Crystallogr. 40, 658\u2013674 (2007).","journal-title":"J. Appl. Crystallogr."},{"key":"63288_CR67","doi-asserted-by":"publisher","first-page":"102100","DOI":"10.1016\/j.jbc.2022.102100","volume":"298","author":"M Asa","year":"2022","unstructured":"Asa, M. et al. Crystal structures of N-myristoylated lipopeptide-bound HLA class I complexes indicate reorganization of B-pocket architecture upon ligand binding. J. Biol. Chem. 298, 102100 (2022).","journal-title":"J. Biol. Chem."},{"key":"63288_CR68","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","volume":"596","author":"J Jumper","year":"2021","unstructured":"Jumper, J. et al. Highly accurate protein structure prediction with AlphaFold. Nature 596, 583\u2013589 (2021).","journal-title":"Nature"},{"key":"63288_CR69","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. D. Biol. Crystallogr. 66, 486\u2013501 (2010).","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"63288_CR70","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1107\/S2059798319011471","volume":"75","author":"D Liebschner","year":"2019","unstructured":"Liebschner, D. et al. Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix. Acta Crystallogr D. Struct. Biol. 75, 861\u2013877 (2019).","journal-title":"Acta Crystallogr D. Struct. Biol."},{"key":"63288_CR71","doi-asserted-by":"publisher","first-page":"4440","DOI":"10.1073\/pnas.1603106113","volume":"113","author":"SA Valkenburg","year":"2016","unstructured":"Valkenburg, S. A. et al. Molecular basis for universal HLA-A*0201-restricted CD8\u2009+\u2009T-cell immunity against influenza viruses. Proc. Natl. Acad. Sci. USA 113, 4440\u20134445 (2016).","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-63288-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-63288-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-63288-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T20:44:51Z","timestamp":1757450691000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-63288-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,28]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["63288"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-63288-3","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,28]]},"assertion":[{"value":"8 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8062"}}